Dividends Calendar Earnings Calendar
APVO

APVO | Aptevo Therapeutics

Aptevo Therapeutics
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Seattle, Washington, United States

Trade prices

  • Volume:
  • Market Cap: 62.4M
  • Prev closed: 1.62
  • Open: 1.62
  • High: 1.72
  • Low: 1.62
  • 52 week low: 1.11
  • 52 week high: 6.35
  • Dividends:No Dividends

Next ER: November 16, 2021 



Top Stories (APVO)

    Company Profile

    Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients? lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology ? the ADAPTIR? modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer and autoimmune diseases.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 30, 2022
    November 12, 2021-1.45 / -1.483.1M / 3.65M
    August 13, 2021-1.78 / -23.11M / 1.35MBeat!
    August 12, 2021-2.1 / -21.35M / 900K
    May 11, 2021-1.74 / -1.672.42M / 2.42MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Nov 24, 2021 11.95 12.41
    15.33
    10.81
    24.75M -29.83%
    Nov 23, 2021 17.03 9.51
    22.08
    8.36
    160.51M 162.81%
    Nov 22, 2021 6.48 7.41
    7.69
    6.38
    608.26K -11.23%
    Nov 19, 2021 7.30 8.07
    8.52
    7.20
    435.91K -9.88%
    Nov 18, 2021 8.10 10.07
    10.49
    7.78
    795.02K -19.16%
    Nov 17, 2021 10.02 9.58
    10.05
    9.40
    72.56K 4.59%
    Nov 16, 2021 9.58 9.85
    10.25
    9.40
    199.31K -1.44%
    Nov 15, 2021 9.72 11.48
    11.60
    9.50
    278.64K -16.49%
    Nov 12, 2021 11.64 12.92
    13.28
    11.55
    189.69K -8.71%
    Nov 11, 2021 12.75 13.20
    13.84
    12.41
    89.40K -0.39%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2016
    • Employees:80

    News

    News for (APVO)

    This company doesn't provide a dividend.


    Talk about Aptevo Therapeutics below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 16, 2021 (Same day)

    wmt clls ntes.ch hd vod armk se tdg stne doyu jmia vrex 


    Jump to (Finance sites)

    Their Official Profiles 

    LinkedIn

    Other stocks 

    baba jnj rht ash dish lrcx kr len schw lyb mrvl gwre 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.